Pulmonary veno-occlusive disease (PVOD) is a rare disease in the subgroup of conditions known as pulmonary arterial hypertension. Although a histological examination is needed for a definitive diagnosis, a noninvasive diagnosis is required for patients with pulmonary hypertension because a lung biopsy is deemed risky. We herein report a 32-year-old woman diagnosed with PVOD via a surgical lung biopsy and autopsy whose disease showed radiological findings mimicking those of hypersensitivity pneumonitis (pneumonia) at the time of the transbronchial lung biopsy, without obvious pulmonary hypertension on admission. When clinicians encounter patients with interstitial lung disease, they should not forget the possibility of PVOD and should be alert for emerging pulmonary hypertension.
Introduction
Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension (PH) characterized by the preferential involvement of the pulmonary venous system (1, 2) . Although histology remains the gold standard for a definitive diagnosis of PVOD, a lung biopsy is contraindicated in the setting of clinically significant PH (2) . Thus, in previous studies, the diagnosis of PVOD was based on histology from an explanted lung or an autopsy (3, 4) .
We herein report a rare case of PVOD diagnosed via a surgical lung biopsy (SLB) and autopsy, exhibiting radiological findings mimicking those of hypersensitivity pneumonitis (pneumonia) at the time of the transbronchial lung biopsy.
Case Report
A 32-year-old woman who had never smoked was referred to Kinki-Chuo Chest Medical Center with a 2-month history of exertional dyspnea, desaturation, and bilateral lung ground-glass opacity (GGO) on chest computed tomography (CT) in November 2010. She had had pneumonia and bronchial asthma when she was 14 years of age. She was not taking any medications, had no pets, and reported no excessive exposure to dust. She had worked in food processing jobs in supermarkets since the 19 years of age. Her mother had Basedow's disease and epilepsy, and her younger brother had congenital deafness while the patient had no hearing loss.
A physical examination on admission revealed the following: body height, 157 cm; body weight, 99 kg; body mass ; no palpable surface lymph nodes; no fine crackles heard on chest auscultation; no clubbing of the fingers; and no skin rashes. The laboratory findings of peripheral blood on admission were as follows: white blood count, 5,200/μL; lactate dehydrogenase, 253 IU/L; C-reactive protein, 0.09 mg/dL; Krebs von den Lungen-6 (KL-6), 317 U/mL (normal, <500); surfactant protein (SP)-D, 171 ng/mL (normal, <110); SP-A, 74.7 ng/ mL (normal, <43.8); angiotensin converting enzyme, 10.3 U/L (normal range, 8.3-21.4); and brain natriuretic peptide (BNP), 10.3 pg/mL (normal, <43.0). A tuberculin skin reaction test was negative. Chest radiography revealed bilateral GGO (Fig. 1a) , and chest high-resolution CT (HRCT) revealed GGO with a centrilobular pattern in all lung fields (Fig. 1c, e) . Pulmonary function tests revealed almost normal values with the exception of a reduced percentage of predicted lung diffusion capacity for carbon monoxide (%DLCO) of 46.5%. An arterial blood gas analysis revealed a reduced partial pressure of oxygen in the arterial blood of 53.1 Torr and an increased alveolar-arterial oxygen difference of 56.2 Torr. Her walking distance in the 6-minute walk test (6MWT) was 54 m with a decrease in saturation of arterial percutaneous blood oxygen (SpO2) to 85%. Ultrasound cardiography (UCG) showed nearly normal left ventricular wall motion and a tricuspid regurgitation pressure gradient (TRPG) of 33 mmHg. Ventilation perfusion scintig- raphy showed no mismatch and no defect. A bronchoscopic examination revealed normal bronchial mucosa. Bronchoalveolar lavage (BAL) was performed in the right B 5 a. The recovery rate of BAL fluid (BALF) was 72%, and the total cell count in BALF was 7.09×10 5 /mL with subset counts of 96.5% macrophages, 3.0% lymphocytes, and 0.5% neutrophils. The CD4/CD8 ratio of the lymphocytes was 1.13, and no pathogens were detected. Hemosiderin-laden macrophages were observed in the BALF. The Golde score to assess alveolar hemorrhaging was 93 (normal 0-20, medium 20-70, high >70) (5) .
A transbronchial lung biopsy (TBLB) was obtained from B 8 a and B 3 a of the right lung. The two lung specimens from the right B 8 a showed mural alveolitis with fibrotic thickening and mild infiltration of lymphoid cells and a few eosinophils in the alveolar walls. Macrophages in the terminal air spaces showed brown pigments in the cytoplasm, suggesting hemosiderin. Occlusion/stenosis of the pulmonary veins was not evident in the TBLB specimens (Fig. 2) . The two lung specimens from the right B 3 a showed mucin and fragmented ciliated epithelium without alveolar structures (not shown). No malignant cells or granulomas were detected. An SLB was not conducted at the time due to the patient's obesity. Approximately 1 year after the TBLB, the patient's body weight had decreased to 86 kg (BMI=34.9), and a surgical biopsy was performed on the left lung (S 4 and S 8 ) in November 2011. Pulmonary hypertension was not examined precisely before the lung biopsy, with increased titers of amino-terminal pro-BNP 481 ng/mL (normal, <125). After the lung biopsy, she required continuous positive airway pressure (CPAP) therapy for two days due to severe respiratory failure. The SLB specimens showed multifocal centrilobular accentuation with fibrotic lesions of the alveolar walls and luminal stenosis and occlusion of the small pulmonary veins. Hemosiderin-laden macrophages were confirmed in the alveolar airspaces via Berlin blue staining, suggesting chronic hemorrhaging in the alveolar areas (6) . Based on these histopathologic findings, we made a diagnosis of PVOD in November 2011 (Fig. 3) . The alveolar walls involved in the pathologic spectrum of PVOD showed thickening with capillary proliferation [so-called pulmonary capillary hemangiomatosis (PCH)-like lesions]. Many muscular pulmonary arteries showed medial thickening. Intimal thickening was observed in a small number of muscular pulmonary arteries. PCH-like lesions were not observed in the bronchiolovascular sheath, interlolular septae or visceral pleura (Fig. 4) . The patient was treated with oxygen therapy with no specific medication. She was hospitalized again to prepare for lung transplantation in January 2012. At that time (January 2012), chest radiography showed increased GGO and enlargement of the pulmonary artery (Fig. 1b) . HRCT revealed increased GGO, interlobular septal thickening, peribronchovascular interstitial thickening, and a mild degree of bilateral pleural effusion. In addition, bronchial stenosis was suspected. (Fig. 1d and f) . UCG revealed that the TRPG had increased to 76 mmHg, and the left ventricle was compressed by the right one. Right heart cardiac catheterization revealed a mean pulmonary artery pressure, 45 mmHg; pulmonary capillary wedge pressure, 14 mmHg; cardiac output, 4.14 L/m; cardiac index, 2.17 L/min/m 2 ; and pulmonary vascular resistance, 738.5 dyne·sec·cm -5 . She was registered as a lung transplant recipient in the same month. As her condition, including right heart failure and respiratory failure, was worsening, invasive positive pressure ventilation was initiated in the respiratory care unit in February 2012. However, her cardiopulmonary function continued to worsen, and she ultimately passed away on the day ventilator management was initiated in February 2012, one month after being registered for a lung transplant (Fig. 5) .
Before her death, no drugs, including steroids, immunosuppressive agents, or specific agents, were administered for pulmonary hypertension. A systematic autopsy was performed. Her body weight was approximately 80 kg. Essential abnormalities were almost entirely restricted to the lungs and heart, except for two uterine leiomyomas. The pleural fluid volume was 645 mL in the right pleural cavity and 295 mL in the left pleural cavity. The pericardial fluid was 50 (Fig. 6) . The myocardial cells in the right ventricle were hypertrophic compared to those in the left ventricle (Fig. 7) .
No malignant neoplasms or granulomas were noted in the 85 paraffin blocks taken from the thoracic and abdominal organs. The 36 autopsy specimens of the lungs were taken from all lobes. The lung tissue findings confirmed PVOD histologically, with a progressive form of fibrotic lesions along the alveolar walls and centrilobular accentuation, as well as occlusion of the small pulmonary veins with intimal fibrosis and hemosiderin-laden macrophages in the pulmonary alveoli (Fig. 8) . Many muscular pulmonary arteries showed increased thickness of the medial layer, as in Fig. 4 . Several muscular arteries showed a marked increase in the thickness of the medial and intimal layers. Alveolar walls with centrilobular accentuation showed thickening with PCH-like lesions. However, the PCH-like lesions were not observed in the bronchiolovascular sheaths, interlobular septae, or visceral pleura (Fig. 9) . The major pulmonary artery trunk showed mild atherosclerotic lesions (not shown). The bronchial structures of the lungs showed mild-to-moderate luminal stenosis due to the edematous lesions, dilation of lymphatic vessels, and engorgement of small blood vessels in the subepithelial layers with preservation of the ciliated epithelial layers (Fig. 10) . The direct cause of death was considered to be a marked increase in the resistance of the pulmonary circulation due to luminal occlusion of numerous small pulmonary veins and secondary right-sided cardiac failure.
Discussion
We herein report a rare case of PVOD diagnosed via an SLB. Clinically, this was thought to be a case of idiopathic PVOD at the time of the SLB (November 2011) without a specific trigger factor (2), although her younger brother was later diagnosed with PVOD at another hospital a few years later. The PVOD in the present case might have been hereditary, although there was no genetic examination performed. To our knowledge, this is the first report of the histological characteristics of PVOD based on three successive histological examinations (TBLB, SLB, and postmortem autopsy findings). It took time to make a definitive diagnosis of the disease because the HRCT findings were similar to those associated with subacute hypersensitivity pneumonitis, and the pulmonary hypertension in this patient was not obvious on admission. It took approximately one year for the patient to receive an SLB after her initial admission and TBLB, primarily due to her obesity.
Although a histological analysis of a lung sample is still considered the gold standard for obtaining a definitive diag- nosis of PVOD, an SLB is too invasive for these frail patients (2) . The histopathologic diagnosis of PVOD is therefore rarely made via an SLB. The authors were unable to make a diagnosis of PVOD using TBLB specimens, although unexplained hemosiderosis of the alveolar macrophages was noted in the setting of diffuse alveolar septal fibrosis and inflammation in our non-smoker patient. In most cases reported in the literature, the diagnosis of PVOD is based on autopsy specimens (3, 4). Thus, this was a rare case of PVOD diagnosed via an SLB and autopsy in addition to the TBLB findings.
The American Thoracic Society/European Respiratory Society guidelines recommend that multidisciplinary discussions including SLB findings be held in order to diagnose idiopathic interstitial pneumonias (7); however, SLBs are associated with a risk of morbidity and mortality in patients with pulmonary hypertension (8) . Indeed, the current patient developed severe respiratory failure after the SLB, requiring immediate CPAP for two days in the respiratory care unit.
The Japan Intractable Diseases Information Center suggests the following clinical diagnostic criteria for PVOD (9): 1) pulmonary artery hypertension including a mean pulmonary artery pressure at rest " 25 mmHg, pulmonary vascular resistance " 3 Wood Units, and pulmonary wedge pressure ! 15 mmHg from right heart catheterization; 2) HRCT findings of thickness of the interlobular septa, small nodules, reticular opacities, GGOs and swelling of the mediastinal lymph nodes, and exclusion of other interstitial lung diseases; and 3) induction of pulmonary edema by specific pulmonary artery dilator agents, such as endothelin receptor antagonists, phosphodiesterase 5 inhibitors, and prostacyclin. A reduced %DLCO, reduced arterial partial pressure of oxygen and reduced peripheral capillary oxygen saturation in the 6MWT (2), and occult alveolar hemorrhaging observed in the BAL (2, 6) also suggest a diagnosis of PVOD. In the current patient, PVOD was not suspected during the first admission because pulmonary hypertension was not obvious and the chest CT findings were similar to those associated with other interstitial lung diseases complicated by obesity. Subacute hypersensitivity pneumonitis was considered at the time of the TBLB due to the two-month history of exertional dyspnea, centrilobular GGO found on HRCT, and TBLB findings of mural alveolitis with infiltration of lymphoid cells in the alveolar walls. However, her condition was atypical of subacute hypersensitivity pneumonitis because there was 1) no increase in numbers of lymphocytes in the BALF, 2) no increase in serum levels of KL-6, 3) no improvement even after hospitalization that included environmental isolation during treatment, and 4) observations of hemosiderosis in the alveolar macrophages in the TBLB specimens despite no history of smoking (10) . Although it was a relatively obscure possibility, in retrospect, we should have investigated the possibility of PVOD by performing non-invasive examinations before the SLB and started preparations for a lung transplant as soon as possible.
In conclusion, we encountered a rare case of PVOD diag-nosed via an SLB and autopsy with histologic findings of TBLB specimens that were obtained one year before the SLB. When clinicians encounter patients with interstitial lung disease, they should not forget the possibility of PVOD and be alert for emerging pulmonary hypertension. When pathologists observe unexplained pulmonary hemosiderosis of alveolar macrophages in the TBLB specimens, as shown in Fig. 2 , in the clinical setting of bilateral diffuse infiltrative lung disease, especially in non-smokers, they also should consider the possibility of PVOD in order to improve the prognosis.
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